Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

NCT01568489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Atopic Dermatitis

Interventions

DRUG: HL-009 Liposomal Gel
DRUG: Placebo

Sponsor

HanAll BioPharma Co., Ltd.